WPD Pharmaceuticals, Inc. is a biotechnology research and development company, which engages in the research and development of medicinal products involving biological compounds and small molecules. Its products include WPD101, Berubicin, WP1066, WP1732, WPD102, WPD103, WP1220, and Annamycin. The company was founded on July 4, 2006 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of WPD Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. WPD Pharmaceuticals Inc market cap is $324,764.00.
What is the 52-week high for WPD Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. WPD Pharmaceuticals Inc 52 week high is $0.34 as of September 03, 2026.
What is the 52-week low for WPD Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. WPD Pharmaceuticals Inc 52 week low is $0.07 as of September 03, 2026.
What is WPD Pharmaceuticals Inc stock price today?
WPD Pharmaceuticals Inc stock price today is $0.07.
What was WPD Pharmaceuticals Inc stock price yesterday?
WPD Pharmaceuticals Inc stock price yesterday was $0.19.
What is the 50-day moving average of WPD Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. WPD Pharmaceuticals Inc 50-day moving average is $0.34.